HeXun Biosciences Balance Sheet

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	208.2	200.99	257.67	119.74	85.03
Short-Term Investments	301.43	172	72	72	-
Cash & Short-Term Investments	509.63	372.99	329.67	191.74	85.03
Cash Growth	36.63%	13.14%	71.94%	125.51%	-
Accounts Receivable	74.56	84.68	22.28	4.98	-
Other Receivables	0.72	0.23	-	-	-
Receivables	75.28	84.91	22.28	4.98	-
Inventory	6.02	15.58	4.6	-	-
Prepaid Expenses	9.51	8.33	6.85	9.44	8.37
Other Current Assets	9.18	1.44	0.27	5.08	0.01
Total Current Assets	609.61	483.25	363.67	211.24	93.4
Property, Plant & Equipment	148.22	139.1	113.93	94.27	102.83
Other Intangible Assets	20.88	26.67	34.26	41.23	1.75
Long-Term Deferred Tax Assets	1.3	1.57	-	-	-
Other Long-Term Assets	57.07	56.34	59.57	57.41	96.64
Total Assets	837.07	706.92	571.43	404.15	294.62
Accounts Payable	3.17	4.24	2.43	3.23	2.81
Accrued Expenses	24.74	13.1	9.65	3.21	1.42
Current Portion of Long-Term Debt	-	-	2.55	2.35	0.59
Current Portion of Leases	3.95	3.04	2.84	2.13	2.07
Current Income Taxes Payable	10.76	15.65	-	-	-
Current Unearned Revenue	13.96	8.7	1.73	3.6	-
Other Current Liabilities	5.97	9.03	10.98	5.51	0.93
Total Current Liabilities	62.54	53.76	30.17	20.03	7.83
Long-Term Debt	-	-	34.9	37.26	39.41
Long-Term Leases	32.62	31.98	32.32	29.9	32.03
Long-Term Unearned Revenue	-	-	-	1.5	-
Pension & Post-Retirement Benefits	-	-	0.08	-	-
Long-Term Deferred Tax Liabilities	0.3	-	-	-	-
Other Long-Term Liabilities	-	0.6	0.6	0.6	0.6
Total Liabilities	95.47	86.34	98.07	89.28	79.87
Common Stock	460	460	460	410	360
Additional Paid-In Capital	139.41	130.3	130.3	55.3	-
Retained Earnings	142.18	30.28	-116.95	-150.44	-145.25
Shareholders' Equity	741.6	620.58	473.36	314.87	214.75
Total Liabilities & Equity	837.07	706.92	571.43	404.15	294.62
Total Debt	36.58	35.02	72.61	71.64	74.1
Net Cash (Debt)	473.05	337.97	257.06	120.11	10.93
Net Cash Growth	39.97%	31.47%	114.03%	999.17%	-
Net Cash Per Share	10.28	7.34	5.67	3.20	0.36
Filing Date Shares Outstanding	46	46	46	46	30.51
Total Common Shares Outstanding	46	46	46	41	30.51
Working Capital	547.06	429.49	333.5	191.22	85.58
Book Value Per Share	16.12	13.49	10.29	7.68	7.04
Tangible Book Value	720.71	593.91	439.09	273.64	213.01
Tangible Book Value Per Share	15.67	12.91	9.55	6.67	6.98
Machinery	139.67	118.95	82.49	63.57	63.23
Leasehold Improvements	31.9	29.82	28	21.69	20.92

Source: S&P Global Market Intelligence. Standard template. Financial Sources.